United States Neuropathy Pain Treatment Market Report 2017

United States Neuropathy Pain Treatment Market Report 2017

1 Neuropathy Pain Treatment Overview

1.1 Product Overview and Scope of Neuropathy Pain Treatment

1.2 Classification of Neuropathy Pain Treatment by Product Category

1.2.1 United States Neuropathy Pain Treatment Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Neuropathy Pain Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Diabetic neuropathy

1.2.4 Chemotherapy-induced neuropathic pain

1.2.5 Postherpetic neuralgia

1.3 United States Neuropathy Pain Treatment Market by Application/End Users

1.3.1 United States Neuropathy Pain Treatment Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Calcium channel alpha 2-delta ligands

1.3.3 Serotonin-norepinephrine reuptake inhibitors

1.3.4 TCA

1.3.5 Opioid analgesics

1.4 United States Neuropathy Pain Treatment Market by Region

1.4.1 United States Neuropathy Pain Treatment Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Neuropathy Pain Treatment Status and Prospect (2012-2022)

1.4.3 Southwest Neuropathy Pain Treatment Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Neuropathy Pain Treatment Status and Prospect (2012-2022)

1.4.5 New England Neuropathy Pain Treatment Status and Prospect (2012-2022)

1.4.6 The South Neuropathy Pain Treatment Status and Prospect (2012-2022)

1.4.7 The Midwest Neuropathy Pain Treatment Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Neuropathy Pain Treatment (2012-2022)

1.5.1 United States Neuropathy Pain Treatment Sales and Growth Rate (2012-2022)

1.5.2 United States Neuropathy Pain Treatment Revenue and Growth Rate (2012-2022)

2 United States Neuropathy Pain Treatment Market Competition by Players/Suppliers

2.1 United States Neuropathy Pain Treatment Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Neuropathy Pain Treatment Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Neuropathy Pain Treatment Average Price by Players/Suppliers (2012-2017)

2.4 United States Neuropathy Pain Treatment Market Competitive Situation and Trends

2.4.1 United States Neuropathy Pain Treatment Market Concentration Rate

2.4.2 United States Neuropathy Pain Treatment Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Neuropathy Pain Treatment Manufacturing Base Distribution, Sales Area, Product Type

3 United States Neuropathy Pain Treatment Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Neuropathy Pain Treatment Sales and Market Share by Region (2012-2017)

3.2 United States Neuropathy Pain Treatment Revenue and Market Share by Region (2012-2017)

3.3 United States Neuropathy Pain Treatment Price by Region (2012-2017)

4 United States Neuropathy Pain Treatment Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Neuropathy Pain Treatment Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Neuropathy Pain Treatment Revenue and Market Share by Type (2012-2017)

4.3 United States Neuropathy Pain Treatment Price by Type (2012-2017)

4.4 United States Neuropathy Pain Treatment Sales Growth Rate by Type (2012-2017)

5 United States Neuropathy Pain Treatment Sales (Volume) by Application (2012-2017)

5.1 United States Neuropathy Pain Treatment Sales and Market Share by Application (2012-2017)

5.2 United States Neuropathy Pain Treatment Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Neuropathy Pain Treatment Players/Suppliers Profiles and Sales Data

6.1 Depomed

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Neuropathy Pain Treatment Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Depomed Neuropathy Pain Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Eli Lilly

6.2.2 Neuropathy Pain Treatment Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Eli Lilly Neuropathy Pain Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Endo International

6.3.2 Neuropathy Pain Treatment Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Endo International Neuropathy Pain Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Pfizer

6.4.2 Neuropathy Pain Treatment Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Pfizer Neuropathy Pain Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Allodynic Therapeutics

6.5.2 Neuropathy Pain Treatment Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Allodynic Therapeutics Neuropathy Pain Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Arbor Pharmaceuticals

6.6.2 Neuropathy Pain Treatment Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Arbor Pharmaceuticals Neuropathy Pain Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Astellas Pharma

6.7.2 Neuropathy Pain Treatment Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Astellas Pharma Neuropathy Pain Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 biogen

6.8.2 Neuropathy Pain Treatment Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 biogen Neuropathy Pain Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 CAPNIA

6.9.2 Neuropathy Pain Treatment Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 CAPNIA Neuropathy Pain Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 DAEWOONG

6.10.2 Neuropathy Pain Treatment Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 DAEWOONG Neuropathy Pain Treatment Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Daiichi Sankyo

6.30 D

7 Neuropathy Pain Treatment Manufacturing Cost Analysis

7.1 Neuropathy Pain Treatment Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Neuropathy Pain Treatment

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Neuropathy Pain Treatment Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Neuropathy Pain Treatment Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Neuropathy Pain Treatment Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Neuropathy Pain Treatment Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Neuropathy Pain Treatment Sales Volume Forecast by Type (2017-2022)

11.3 United States Neuropathy Pain Treatment Sales Volume Forecast by Application (2017-2022)

11.4 United States Neuropathy Pain Treatment Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Neuropathy Pain Treatment

Figure United States Neuropathy Pain Treatment Market Size (MT) by Type (2012-2022)

Figure United States Neuropathy Pain Treatment Sales Volume Market Share by Type (Product Category) in 2016

Figure Diabetic neuropathy Product Picture

Figure Chemotherapy-induced neuropathic pain Product Picture

Figure Postherpetic neuralgia Product Picture

Figure United States Neuropathy Pain Treatment Market Size (MT) by Application (2012-2022)

Figure United States Sales Market Share of Neuropathy Pain Treatment by Application in 2016

Figure Calcium channel alpha 2-delta ligands Examples

Figure Serotonin-norepinephrine reuptake inhibitors Examples

Figure TCA Examples

Figure Opioid analgesics Examples

Figure United States Neuropathy Pain Treatment Market Size (Million USD) by Region (2012-2022)

Figure The West Neuropathy Pain Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Neuropathy Pain Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Neuropathy Pain Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Neuropathy Pain Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Neuropathy Pain Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Neuropathy Pain Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Neuropathy Pain Treatment Sales (MT) and Growth Rate (2012-2022)

Figure United States Neuropathy Pain Treatment Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Neuropathy Pain Treatment Market Major Players Product Sales Volume (MT) (2012-2017)

Table United States Neuropathy Pain Treatment Sales (MT) of Key Players/Suppliers (2012-2017)

Table United States Neuropathy Pain Treatment Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Neuropathy Pain Treatment Sales Share by Players/Suppliers

Figure 2017 United States Neuropathy Pain Treatment Sales Share by Players/Suppliers

Figure United States Neuropathy Pain Treatment Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Neuropathy Pain Treatment Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Neuropathy Pain Treatment Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Neuropathy Pain Treatment Revenue Share by Players/Suppliers

Figure 2017 United States Neuropathy Pain Treatment Revenue Share by Players/Suppliers

Table United States Market Neuropathy Pain Treatment Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)

Figure United States Market Neuropathy Pain Treatment Average Price (USD/Kg) of Key Players/Suppliers in 2016

Figure United States Neuropathy Pain Treatment Market Share of Top 3 Players/Suppliers

Figure United States Neuropathy Pain Treatment Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Neuropathy Pain Treatment Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Neuropathy Pain Treatment Product Category

Table United States Neuropathy Pain Treatment Sales (MT) by Region (2012-2017)

Table United States Neuropathy Pain Treatment Sales Share by Region (2012-2017)

Figure United States Neuropathy Pain Treatment Sales Share by Region (2012-2017)

Figure United States Neuropathy Pain Treatment Sales Market Share by Region in 2016

Table United States Neuropathy Pain Treatment Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Neuropathy Pain Treatment Revenue Share by Region (2012-2017)

Figure United States Neuropathy Pain Treatment Revenue Market Share by Region (2012-2017)

Figure United States Neuropathy Pain Treatment Revenue Market Share by Region in 2016

Table United States Neuropathy Pain Treatment Price (USD/Kg) by Region (2012-2017)

Table United States Neuropathy Pain Treatment Sales (MT) by Type (2012-2017)

Table United States Neuropathy Pain Treatment Sales Share by Type (2012-2017)

Figure United States Neuropathy Pain Treatment Sales Share by Type (2012-2017)

Figure United States Neuropathy Pain Treatment Sales Market Share by Type in 2016

Table United States Neuropathy Pain Treatment Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Neuropathy Pain Treatment Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Neuropathy Pain Treatment by Type (2012-2017)

Figure Revenue Market Share of Neuropathy Pain Treatment by Type in 2016

Table United States Neuropathy Pain Treatment Price (USD/Kg) by Types (2012-2017)

Figure United States Neuropathy Pain Treatment Sales Growth Rate by Type (2012-2017)

Table United States Neuropathy Pain Treatment Sales (MT) by Application (2012-2017)

Table United States Neuropathy Pain Treatment Sales Market Share by Application (2012-2017)

Figure United States Neuropathy Pain Treatment Sales Market Share by Application (2012-2017)

Figure United States Neuropathy Pain Treatment Sales Market Share by Application in 2016

Table United States Neuropathy Pain Treatment Sales Growth Rate by Application (2012-2017)

Figure United States Neuropathy Pain Treatment Sales Growth Rate by Application (2012-2017)

Table Depomed Basic Information List

Table Depomed Neuropathy Pain Treatment Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Depomed Neuropathy Pain Treatment Sales Growth Rate (2012-2017)

Figure Depomed Neuropathy Pain Treatment Sales Market Share in United States (2012-2017)

Figure Depomed Neuropathy Pain Treatment Revenue Market Share in United States (2012-2017)

Table Eli Lilly Basic Information List

Table Eli Lilly Neuropathy Pain Treatment Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Eli Lilly Neuropathy Pain Treatment Sales Growth Rate (2012-2017)

Figure Eli Lilly Neuropathy Pain Treatment Sales Market Share in United States (2012-2017)

Figure Eli Lilly Neuropathy Pain Treatment Revenue Market Share in United States (2012-2017)

Table Endo International Basic Information List

Table Endo International Neuropathy Pain Treatment Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Endo International Neuropathy Pain Treatment Sales Growth Rate (2012-2017)

Figure Endo International Neuropathy Pain Treatment Sales Market Share in United States (2012-2017)

Figure Endo International Neuropathy Pain Treatment Revenue Market Share in United States (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Neuropathy Pain Treatment Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Pfizer Neuropathy Pain Treatment Sales Growth Rate (2012-2017)

Figure Pfizer Neuropathy Pain Treatment Sales Market Share in United States (2012-2017)

Figure Pfizer Neuropathy Pain Treatment Revenue Market Share in United States (2012-2017)

Table Allodynic Therapeutics Basic Information List

Table Allodynic Therapeutics Neuropathy Pain Treatment Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Allodynic Therapeutics Neuropathy Pain Treatment Sales Growth Rate (2012-2017)

Figure Allodynic Therapeutics Neuropathy Pain Treatment Sales Market Share in United States (2012-2017)

Figure Allodynic Therapeutics Neuropathy Pain Treatment Revenue Market Share in United States (2012-2017)

Table Arbor Pharmaceuticals Basic Information List

Table Arbor Pharmaceuticals Neuropathy Pain Treatment Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Arbor Pharmaceuticals Neuropathy Pain Treatment Sales Growth Rate (2012-2017)

Figure Arbor Pharmaceuticals Neuropathy Pain Treatment Sales Market Share in United States (2012-2017)

Figure Arbor Pharmaceuticals Neuropathy Pain Treatment Revenue Market Share in United States (2012-2017)

Table Astellas Pharma Basic Information List

Table Astellas Pharma Neuropathy Pain Treatment Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Astellas Pharma Neuropathy Pain Treatment Sales Growth Rate (2012-2017)

Figure Astellas Pharma Neuropathy Pain Treatment Sales Market Share in United States (2012-2017)

Figure Astellas Pharma Neuropathy Pain Treatment Revenue Market Share in United States (2012-2017)

Table biogen Basic Information List

Table biogen Neuropathy Pain Treatment Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure biogen Neuropathy Pain Treatment Sales Growth Rate (2012-2017)

Figure biogen Neuropathy Pain Treatment Sales Market Share in United States (2012-2017)

Figure biogen Neuropathy Pain Treatment Revenue Market Share in United States (2012-2017)

Table CAPNIA Basic Information List

Table CAPNIA Neuropathy Pain Treatment Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure CAPNIA Neuropathy Pain Treatment Sales Growth Rate (2012-2017)

Figure CAPNIA Neuropathy Pain Treatment Sales Market Share in United States (2012-2017)

Figure CAPNIA Neuropathy Pain Treatment Revenue Market Share in United States (2012-2017)

Table DAEWOONG Basic Information List

Table DAEWOONG Neuropathy Pain Treatment Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure DAEWOONG Neuropathy Pain Treatment Sales Growth Rate (2012-2017)

Figure DAEWOONG Neuropathy Pain Treatment Sales Market Share in United States (2012-2017)

Figure DAEWOONG Neuropathy Pain Treatment Revenue Market Share in United States (2012-2017)

Table Daiichi Sankyo Basic Information List

Table D Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Neuropathy Pain Treatment

Figure Manufacturing Process Analysis of Neuropathy Pain Treatment

Figure Neuropathy Pain Treatment Industrial Chain Analysis

Table Raw Materials Sources of Neuropathy Pain Treatment Major Players/Suppliers in 2016

Table Major Buyers of Neuropathy Pain Treatment

Table Distributors/Traders List

Figure United States Neuropathy Pain Treatment Sales Volume (MT) and Growth Rate Forecast (2017-2022)

Figure United States Neuropathy Pain Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Neuropathy Pain Treatment Price (USD/Kg) Trend Forecast (2017-2022)

Table United States Neuropathy Pain Treatment Sales Volume (MT) Forecast by Type (2017-2022)

Figure United States Neuropathy Pain Treatment Sales Volume (MT) Forecast by Type (2017-2022)

Figure United States Neuropathy Pain Treatment Sales Volume (MT) Forecast by Type in 2022

Table United States Neuropathy Pain Treatment Sales Volume (MT) Forecast by Application (2017-2022)

Figure United States Neuropathy Pain Treatment Sales Volume (MT) Forecast by Application (2017-2022)

Figure United States Neuropathy Pain Treatment Sales Volume (MT) Forecast by Application in 2022

Table United States Neuropathy Pain Treatment Sales Volume (MT) Forecast by Region (2017-2022)

Table United States Neuropathy Pain Treatment Sales Volume Share Forecast by Region (2017-2022)

Figure United States Neuropathy Pain Treatment Sales Volume Share Forecast by Region (2017-2022)

Figure United States Neuropathy Pain Treatment Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources